🟢 Lantern Pharma is trading 9.66% up in pre-market with no identified company-specific catalyst

Lantern Pharma is trading 9.66% up at $1.64, with no new company-specific catalyst identified for September 22, 2026.

• The latest notable announcement is a September 23 webinar covering Open-Medicine AI’s business model and roadmap, but available reporting does not explicitly connect it to the pre-market move.
• Broader pre-market indices are modestly lower, so market-wide strength does not clearly explain the gain.
• Confidence remains low pending additional disclosures.